This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Connaught Laboratories Limited. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Innovations of Phillipe Moingeon in Cervical Cancer Immunization
Introduction
Phillipe Moingeon is a notable inventor based in F-Pommiers, France. He has made significant contributions to the field of immunology, particularly in the development of innovative solutions for cervical cancer prevention.
Latest Patents
Moingeon holds a patent for "Vectors for DNA immunization against cervical cancer." This patent involves a nucleic acid molecule that encodes at least one non-toxic T-cell epitope of the E6 and/or E7 antigens of a strain of human papilloma virus (HPV) associated with cervical cancer, such as HPV-16. The invention includes a promoter that is operatively coupled to the nucleic acid molecule, facilitating its expression in a host when the vector is administered. He has 1 patent to his name.
Career Highlights
Phillipe Moingeon is associated with Connaught Laboratories Limited, where he has been instrumental in advancing research and development in the field of vaccines and immunization strategies. His work has been pivotal in addressing public health challenges related to cervical cancer.
Collaborations
Some of his notable coworkers include Diane M Gajewczyk and Roy Persson, who have collaborated with him on various projects aimed at enhancing immunological responses against cancer.
Conclusion
Phillipe Moingeon's innovative work in DNA immunization represents a significant advancement in the fight against cervical cancer. His contributions continue to inspire further research and development in the field of immunology.